Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tate

Showing results (171-180 of 395) with videos related to

Pageof 40
Sort By:
European Journal of Clinical Investigation|August 1, 1984
An erythrocyte transketolase isoenzyme pattern associated with the Wernicke-Korsakoff syndromeP F Nixon, M J Kaczmarek, J Tate, et al.
Journal of the Royal Society of Medicine|November 1, 1987
X-ray and ultrasound localization of non-palpable breast lesions and difficulties in managementJ J Tate, G T Royle, P McDonald, et al.
Gynecologic Oncology|February 8, 2006
The role of maintenance therapy and novel taxanes in ovarian cancerThomas J Herzog, Robert L Coleman, Maurie Markman, et al.
British Journal of Pharmacology|February 13, 2007
The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptorsP G Purohit, R J Tate, E Pow, et al.
Endoscopy|July 11, 2022
Effect of pre-resection biopsy on detection of advanced dysplasia in large nonpedunculated colorectal polyps undergoing endoscopic mucosal resectionMichael X Ma, David J Tate, Mayenaaz Sidhu, et al.
Nature Structural Biology|July 30, 1999
The crystal structure of cricket paralysis virus: the first view of a new virus familyJ Tate, L Liljas, P Scotti, et al.
Gynecologic Oncology|September 19, 2003
Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group studyJ Tate Thigpen, John A Blessing, George Olt, et al.
Biomaterials|December 28, 2011
Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery systemFanny Lemarié, Daniel R Croft, Rothwelle J Tate, et al.
International Journal of Nanomedicine|April 4, 2022
Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer CellsJamal Almowalad, Partha Laskar, Sukrut Somani, et al.
Journal of the Royal Society of Medicine|December 1, 1989
After surgery for breast cancer: which mode of surveillance?J J Tate, P C Clifford, G T Royle, et al.
Pageof 40

Showing results (171-180 of 395) with videos related to

Sort By:
Pageof 40
European Journal of Clinical Investigation|August 1, 1984
An erythrocyte transketolase isoenzyme pattern associated with the Wernicke-Korsakoff syndromeP F Nixon, M J Kaczmarek, J Tate, et al.
Journal of the Royal Society of Medicine|November 1, 1987
X-ray and ultrasound localization of non-palpable breast lesions and difficulties in managementJ J Tate, G T Royle, P McDonald, et al.
Gynecologic Oncology|February 8, 2006
The role of maintenance therapy and novel taxanes in ovarian cancerThomas J Herzog, Robert L Coleman, Maurie Markman, et al.
British Journal of Pharmacology|February 13, 2007
The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptorsP G Purohit, R J Tate, E Pow, et al.
Endoscopy|July 11, 2022
Effect of pre-resection biopsy on detection of advanced dysplasia in large nonpedunculated colorectal polyps undergoing endoscopic mucosal resectionMichael X Ma, David J Tate, Mayenaaz Sidhu, et al.
Nature Structural Biology|July 30, 1999
The crystal structure of cricket paralysis virus: the first view of a new virus familyJ Tate, L Liljas, P Scotti, et al.
Gynecologic Oncology|September 19, 2003
Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group studyJ Tate Thigpen, John A Blessing, George Olt, et al.
Biomaterials|December 28, 2011
Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery systemFanny Lemarié, Daniel R Croft, Rothwelle J Tate, et al.
International Journal of Nanomedicine|April 4, 2022
Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer CellsJamal Almowalad, Partha Laskar, Sukrut Somani, et al.
Journal of the Royal Society of Medicine|December 1, 1989
After surgery for breast cancer: which mode of surveillance?J J Tate, P C Clifford, G T Royle, et al.
Pageof 40